在炎症性肠病患者中遵守地中海饮食和饮食质量:单中心,观察性,病例对照研究
Marta Cadoni1,2, Agnese Favale1,2, Rita Piras1
1Department of Medical Science and Public Health, University of Cagliari, 09124 Cagliari, Italy.
Nutrients
|June 19, 2024
概括
炎症性肠病 (IBD) 患者的饮食质量较差,对地中海饮食 (MedDiet) 的坚持也较低. 特定的IBD亚型,如乳头结肠疾病克罗恩病和广泛的性结肠炎,显示MedDiet的接受率降低.
科学领域:
- 胃肠病学 胃肠病学
- 营养科学 营养科学
- 流行病学 流行病学
背景情况:
- 炎症性肠病 (IBD) 患者的营养状况经常受到损害.
- 在IBD人群中遵守地中海饮食 (MedDiet) 尚不清楚.
- 饮食质量 (DQ) 和MedDiet的坚持是管理IBD的关键因素.
研究的目的:
- 为了评估撒丁岛IBD患者的饮食质量 (DQ) 和MedDiet坚持.
- 为了比较IBD患者和健康对照者之间的DQ和MedDiet坚持.
- 调查疾病特征对DQ和MedDiet坚持的影响.
主要方法:
- 一项涉及50名克罗恩病 (CD) 和50名性结肠炎 (UC) 患者的病例控制研究与100名健康对照进行了匹配.
- 使用饮食质量指数 (DQI-I) 评估饮食质量.
- 使用Medi-Lite工具测量MedDiet的坚持.
主要成果:
- 与对照组相比,IBD患者的DQI-I得分明显较低,无论疾病的局部化或行为如何.
- 与对照组相比,患有严格缩性/伊利欧结肠性CD和广泛的UC的患者的Medi-Lite得分明显较低.
- 总的来说,IBD患者表现出低的DQ,在特定疾病表型中观察到MedDiet坚持减少.
结论:
- 一般来说,IBD患者的饮食质量低于最佳,并且对MedDiet的遵守率较低.
- 减少MedDiet的坚持,特别是在患有乳腺结肠狭窄性CD和广泛的UC的患者中注意到.
- 在IBD中MedDiet的潜在益处可能受到某些患者亚组接受程度较低的限制.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:30Inflammatory Bowel Disease II: Crohn's Disease
213
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
213
01:29Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
161
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
161
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115